Meet Our Supporters

Osteoporosis and Bone Metastasis in Oncology: Addressing Bone Health Treatment Gaps and the Role of Biosimilars

This session will examine the current strategies and challenges in preventing fractures from osteoporosis and skeletal related events from bone metastasis in patients living with cancer.  It will highlight the clinical and economic burden of bone complications and explore the potential of biosimilars to increase access and reduce healthcare costs.

Session sponsored by Sandoz.

Session Chair: Dr. Nicole Kuderer

Agenda: 

• Dr. Matti Aapro – Bone Health in Cancer: Current Strategies and Challenges
• Dr. Gary Layman – Clinical and Economic Burden of Skeletal Complications
• Darrell Wilson – The Patient’s Perspective on Management and Care
• Discussion and Q&A

Best Practices in Antiemetic Control

This symposium will provide an in-depth look at current and emerging strategies to manage chemotherapy-induced nausea and vomiting. Expert-led discussions will focus on the latest guidelines, evidence, and innovative treatment options to improve patient outcomes in oncology.

This educational activity is supported by an educational grant from Helsinn Healthcare SA.

Session Chairs: Dr. Matti Aapro & Prof. Florian Scotté

Agenda:

• Dr. Matti Aapro – Vomiting Beyond Day 5: The Science Explaining Why Some Drugs May Have an Advantage
• Prof. Hirotoshi Iihara – Consideration of Optimal Antiemetic Therapy for ADC Treatment: A Patient-Centered Approach
• Prof. Alex Molasiotis – Nausea: An Unsolved Issue. Tips to Help Patients
• Discussion and Q&A

Advancing Nutritional Care in Oncology: Precision and Multidisciplinary Approaches

The symposium addresses the critical role of nutritional care in oncology, highlighting targeted nutrition interventions and the importance of a multidisciplinary approach. The session will cover the assessment of body composition, energy metabolism, and the collaborative strategies that enhance patient outcomes in cancer care.

Session sponsored by Nestlé Health Science.

Session Chair: Prof. Florian Scotté

Agenda: 

• Dr. Carla Prado – Targeted Nutrition in Oncology: Improving Patient Outcomes Through Nutritional Assessment and Intervention
• Prof. Florian Scotté – Integrative Oncological Nutrition: A Multidisciplinary Approach
• Discussion and Q&A

HER2gether: Multidisciplinary Management of Adverse Events Associated with Certain Metastatic Breast Cancer Treatments

This session will review the importance of using the most efficacious treatment first for HER2-expressing metastatic breast cancer, discuss multidisciplinary management of common adverse events, and educate on best practices to help monitor and manage ILD

Session supported by Daiichi Sankyo Inc. / AstraZeneca.

Session Chair: Dr. Maryam Lustberg

Agenda: 

• Dr. Niharika Dixit – Patient Focused Treatment Decision Making in HER2-low, HER2-ultralow, and HER2-null Metastatic Breast Cancer
• Dr. Maryam Lustberg – Mitigating Common Adverse Events Associated with Metastatic Breast Cancer Treatment
• Dr. Niharika Dixit – The Importance of Proactive Monitoring and Management of ILD
• Ms. Eva Schumacher-Wulf – Exploring the Patient Experience with Metastatic Breast Cancer
• Discussion and Q&A

Multidisciplinary Management of Cancer-Related Skin Side Effects

Multidisciplinary management of cancer-related skin side effects requires a collaborative approach involving oncologists, dermatologists, and other specialists to address skin toxicities, rash, itching, and other skin problems, ensuring optimal patient care and treatment outcomes.

Session sponsored by La Roche-Posay.

Session Chair: Prof. Florian Scotté

Agenda: 

• Dr. Sanjay Juneja – Examining Dermatologic Adverse Events from Anticancer Therapies
• Dr. Lorraine Rosamilia – Dermatological Approach to Management of Skin Side Effects
• Dr. Sanjay Juneja & Pamela Grayson, RN
• Discussion and Q&A